B. 1. Willemze and R. , WHO-EORTC classification for cutaneous lymphomas, Blood, vol.105, issue.10, pp.3768-85, 2005.
DOI : 10.1182/blood-2004-09-3502

M. Beylot-barry, D??finition, classification, diagnostic clinique et histologique des lymphomes T cutan??s, Annales de Dermatologie et de V??n??r??ologie, vol.132, issue.2, pp.5-5, 2005.
DOI : 10.1016/S0151-9638(05)79611-3

H. Bachelez, [Cutaneous lymphomas], Rev Prat, vol.57, issue.5, pp.469-75, 2007.

D. N. Slater, The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants, British Journal of Dermatology, vol.19, issue.5, pp.874-80, 2005.
DOI : 10.1002/ajh.20019

R. Willemze, EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer, Blood, vol.90, issue.1, pp.354-71, 1997.

N. L. Harris, The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997, Modern Pathology, vol.13, issue.2, pp.193-207, 1997.
DOI : 10.1038/modpathol.3880035

M. Setoyama, Y. Katahira, and T. Kanzaki, Clinicopathologic Analysis of 124 Cases of Adult T-Cell Leukemia/Lymphoma with Cutaneous Manifestations: The Smouldering Type with Skin Manifestations Has a Poorer Prognosis than Previously Thought, The Journal of Dermatology, vol.37, issue.12, pp.26-785, 1999.
DOI : 10.1111/j.1346-8138.1999.tb02093.x

G. Delsol, Classification OMS 2008 des lymphomes, Process Citation], pp.20-24, 2008.
DOI : 10.1016/j.annpat.2008.09.002

V. D. Criscione and M. A. Weinstock, Incidence of cutaneous T-cell lymphoma in the United States, Arch Dermatol, issue.7, pp.143-854, 1973.

M. O. Riou-gotta, Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between, Leuk Lymphoma, issue.8, pp.49-1537, 1980.
URL : https://hal.archives-ouvertes.fr/inserm-00484243

J. J. Grob, [Epidemiology of mycosis fungoides], Ann Dermatol Venereol, vol.132, issue.2, pp.5-11, 2005.

M. Saunes, T. I. Lund-nilsen, T. B. Johannesen-yasukawa, and K. , Incidence of primary cutaneous Tcell lymphoma in Norway The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification, Br J Dermatol J Cutan Pathol, vol.13, issue.7, pp.33-487, 2006.

R. Fink-puches, Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients, Blood, vol.99, issue.3, pp.99-800, 2002.
DOI : 10.1182/blood.V99.3.800

D. Francesco and M. A. , Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides, Journal of Medical Microbiology, vol.53, issue.5, pp.53-381, 2004.
DOI : 10.1099/jmm.0.05439-0

K. P. Huang, Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and S??zary Syndrome, Archives of Dermatology, vol.143, issue.1, pp.45-50, 2007.
DOI : 10.1001/archderm.143.1.45

M. W. Bekkenk, Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment, Blood, issue.12, pp.95-3653, 2000.

E. Shabrawi-caelen, L. , H. Kerl, and L. Cerroni, Lymphomatoid Papulosis, Archives of Dermatology, vol.140, issue.4, pp.441-448, 2004.
DOI : 10.1001/archderm.140.4.441

R. Willemze, Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases, Blood, vol.111, issue.2, pp.838-883, 2008.
DOI : 10.1182/blood-2007-04-087288

J. K. Chan, Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm, Blood, issue.12, pp.89-4501, 1997.

S. Mraz-gernhard, Natural Killer/Natural Killer-Like T-Cell Lymphoma, CD56+, Presenting in the Skin: An Increasingly Recognized Entity With an Aggressive Course, Journal of Clinical Oncology, vol.19, issue.8, pp.19-2179, 2001.
DOI : 10.1200/JCO.2001.19.8.2179

E. Berti, Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas, The American Journal of Pathology, vol.155, issue.2, pp.483-92, 1999.
DOI : 10.1016/S0002-9440(10)65144-9

B. Arnulf, Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization, Blood, issue.5, pp.91-1723, 1998.

N. J. Senff, Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers Relative frequency of various forms of primary cutaneous lymphomas, J Clin Oncol J Am Acad Dermatol, vol.5, issue.1, pp.25-1581, 2000.

J. J. Hoefnagel, Primary Cutaneous Marginal Zone B-Cell Lymphoma, Archives of Dermatology, vol.141, issue.9, pp.141-1139, 2005.
DOI : 10.1001/archderm.141.9.1139

F. Grange, Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Archives of Dermatology, vol.143, issue.9, pp.1144-50, 2007.
DOI : 10.1001/archderm.143.9.1144

A. J. Ferreri, Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ???cutaneous variant???, British Journal of Haematology, vol.27, issue.suppl. 2, pp.173-83, 2004.
DOI : 10.1111/j.1365-2141.2004.05177.x

L. Cerroni, and cutaneous B-cell lymphoma, Journal of Cutaneous Pathology, vol.29, issue.8, pp.457-61, 1997.
DOI : 10.1111/j.1600-0560.1997.tb01318.x

J. Feuillard, Clinical and biologic features of CD4+CD56+ malignancies, Blood, vol.99, issue.5, pp.1556-63, 2002.
DOI : 10.1182/blood.V99.5.1556

R. Fink-puches, The Spectrum of Cutaneous Lymphomas in Patients Less than 20 Years of Age, Pediatric Dermatology, vol.25, issue.5, pp.525-558, 2004.
DOI : 10.1046/j.1525-1470.2000.017005369.x

H. H. Chen, C. H. Hsiao, H. C. Chiu-condarco, and T. , Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma Primary cutaneous B-cell lymphoma in a child Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides, Br J Dermatol Fetal Pediatr Pathol J Clin Oncol, vol.147, issue.343, pp.587-91, 2001.

B. Haghighi, Pagetoid Reticulosis (Woringer-Kolopp Disease): An Immunophenotypic, Molecular, and Clinicopathologic Study, Modern Pathology, vol.13, issue.5, pp.502-512, 2000.
DOI : 10.1038/modpathol.3880088

M. Clarijs, Granulomatous Slack Skin: Treatment with Extensive Surgery and Review of the Literature, Dermatology, vol.206, issue.4, pp.393-400, 2003.
DOI : 10.1159/000069967

J. S. Wieselthier, H. K. Koh-von-den-driesch, P. , E. A. Coors-kodama, and K. , S??zary syndrome: Diagnosis, prognosis, and critical review of treatment options, Journal of the American Academy of Dermatology, vol.22, issue.3, pp.381-401, 1990.
DOI : 10.1016/0190-9622(90)70054-L

J. Guitart, Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting, Journal of Cutaneous Pathology, vol.47, issue.4, pp.174-83, 2001.
DOI : 10.1046/j.1365-2133.1997.19342049.x

B. R. Smoller, Histopathology and genetics of cutaneous T-cell lymphoma, Hematology/Oncology Clinics of North America, vol.17, issue.6, pp.1277-311, 2003.
DOI : 10.1016/S0889-8588(03)00115-1

E. Diamandidou, Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis, Blood, vol.92, issue.4, pp.1150-1159, 1998.

S. O. Arulogun, Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation, Blood, vol.112, issue.8, 2008.
DOI : 10.1182/blood-2008-05-154609

E. Olsen, Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC), Blood, vol.110, issue.6, pp.110-1713, 2007.
DOI : 10.1182/blood-2007-03-055749

M. H. Vermeer, Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients, Am J Pathol Arch Dermatol, vol.154, issue.42, pp.138-191, 1999.

E. C. Vonderheid, Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas, Journal of the American Academy of Dermatology, vol.46, issue.1, pp.95-106, 2002.
DOI : 10.1067/mjd.2002.118538

J. M. Weinberg, The clonal nature of circulating Sezary cells, Blood, vol.86, issue.11, pp.4257-62, 1995.

H. J. Sentis, R. Willemze, and E. Scheffer, Histopathologic studies in S??zary syndrome and erythrodermic mycosis fungoides: A comparison with benign forms of erythroderma, Journal of the American Academy of Dermatology, vol.15, issue.6, pp.15-1217, 1986.
DOI : 10.1016/S0190-9622(86)70294-6

N. Ortonne, Significance of circulating T-cell clones in Sezary syndrome, Blood, vol.107, issue.10, pp.4030-4038, 2006.
DOI : 10.1182/blood-2005-10-4239

R. C. Beljaards, Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients, Am J Pathol, issue.6, pp.135-1169, 1989.

M. W. Bekkenk, Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients, Blood, vol.102, issue.6, pp.2213-2222, 1994.
DOI : 10.1182/blood-2002-07-1960

J. J. Hoefnagel, Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance, British Journal of Dermatology, vol.90, issue.6, pp.149-1183, 2003.
DOI : 10.1046/j.1365-2133.2002.47329.x

R. Bergman, Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma, Arch Dermatol, vol.137, issue.4, pp.432-441, 2001.

J. J. Hoefnagel, Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma, Modern Pathology, vol.19, issue.9, pp.1270-1276, 2006.
DOI : 10.1038/modpathol.3800650

J. M. Martin, CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin, Journal of the European Academy of Dermatology and Venereology, vol.146, issue.9, pp.1129-1161, 2003.
DOI : 10.1097/00000478-200207000-00003

S. Oshtory, Usefulness of flow cytometry in the diagnosis of??mycosis fungoides, Journal of the American Academy of Dermatology, vol.57, issue.3, pp.454-62, 2007.
DOI : 10.1016/j.jaad.2007.01.017

R. Ponti, TCR??-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples, Journal of Investigative Dermatology, vol.128, issue.4, pp.1030-1038, 2008.
DOI : 10.1038/sj.jid.5701109

K. Dadej, The Value of Clonality in the Diagnosis and Follow-up of Patients With Cutaneous T-cell Infiltrates, Diagnostic Molecular Pathology, vol.10, issue.2, pp.78-88, 2001.
DOI : 10.1097/00019606-200106000-00002

M. Murphy, Detection of TCR-?? gene rearrangements in early mycosis fungoides by non-radioactive PCR-SSCP, Journal of Cutaneous Pathology, vol.27, issue.5, pp.228-262, 2000.
DOI : 10.1034/j.1600-0560.2000.027005228.x

M. H. Delfau-larue, Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma, Blood, issue.9, pp.96-2987, 2000.

P. I. Schiller, Detection of clonal T cells in lichen planus, Archives of Dermatological Research, vol.292, issue.11, pp.568-577, 2000.
DOI : 10.1007/s004030000178

O. Dereure, E. Levi, and M. E. Kadin, T-Cell Clonality in Pityriasis Lichenoides et Varioliformis Acuta, Archives of Dermatology, vol.136, issue.12, pp.136-1483, 2000.
DOI : 10.1001/archderm.136.12.1483

A. Boer, Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies, British Journal of Dermatology, vol.143, issue.2, pp.394-402, 2008.
DOI : 10.1111/j.1365-2133.2008.08670.x

S. Gellrich, Primary Cutaneous Follicle Center Cell Lymphomas and Large B Cell Lymphomas of the Leg Descend from Germinal Center Cells. A Single Cell Polymerase Chain Reaction Analysis, Journal of Investigative Dermatology, vol.117, issue.6, pp.1512-1532, 2001.
DOI : 10.1046/j.0022-202x.2001.01543.x

A. Boer, Erythema migrans: a reassessment of diagnostic criteria for early cutaneous manifestations of borreliosis with particular emphasis on clonality investigations, British Journal of Dermatology, vol.157, issue.6, pp.1263-71, 2007.
DOI : 10.1067/mjd.2002.120475

C. Hallermann, Chromosomal Aberration Patterns Differ in Subtypes of Primary Cutaneous B Cell Lymphomas, Journal of Investigative Dermatology, vol.122, issue.6, pp.1495-502, 2001.
DOI : 10.1111/j.0022-202X.2003.12635.x

C. Hallermann, New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas, Journal of the American Academy of Dermatology, vol.56, issue.4, pp.588-97, 2007.
DOI : 10.1016/j.jaad.2006.12.026

F. J. Child, Inactivation of Tumor Suppressor Genes p15INK4b and p16INK4a in Primary Cutaneous B Cell Lymphoma, Journal of Investigative Dermatology, vol.118, issue.6, pp.941-949, 2002.
DOI : 10.1046/j.1523-1747.2002.01785.x

J. J. Hoefnagel, Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling, Blood, vol.105, issue.9, pp.3671-3679, 2005.
DOI : 10.1182/blood-2004-04-1594

E. C. Vonderheid and M. G. Bernengo, The S??zary syndrome: hematologic criteria, Hematology/Oncology Clinics of North America, vol.17, issue.6, pp.1367-89, 2003.
DOI : 10.1016/S0889-8588(03)00120-5

N. Pimpinelli, Defining early mycosis fungoides, Journal of the American Academy of Dermatology, vol.53, issue.6, pp.1053-63, 2005.
DOI : 10.1016/j.jaad.2005.08.057

B. Labeille, parapsoriasis en plaque (excepté le pytiriasis lichénoïde) Encycl Méd Chir, Dermatologie, pp.98-165, 2002.

L. Cerroni and G. Goteri, Differential diagnosis between cutaneous lymphoma and pseudolymphoma, Anal Quant Cytol Histol, vol.25, issue.4, pp.191-199, 2003.

Y. H. Kim, TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC), Blood, vol.110, issue.2, pp.110-479, 2007.
DOI : 10.1182/blood-2006-10-054601

Y. H. Kim, Long-term Outcome of 525 Patients With Mycosis Fungoides and S??zary Syndrome, Archives of Dermatology, vol.139, issue.7, pp.139-857, 2003.
DOI : 10.1001/archderm.139.7.857

N. J. Senff, European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas, Blood, vol.112, issue.5, pp.1600-1609, 2008.
DOI : 10.1182/blood-2008-04-152850

N. J. Senff, H. C. Kluin-nelemans, R. Willemze, and R. , Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma, British Journal of Haematology, vol.17, issue.1, pp.52-58, 2000.
DOI : 10.1182/blood-2002-04-1279

F. Grange, [Prognosis of primary cutaneous T-cell lymphomas], Ann Dermatol Venereol, vol.132, issue.2, pp.5-13, 2005.

H. S. Zackheim, Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients, Journal of the American Academy of Dermatology, vol.40, issue.3, pp.418-443, 1999.
DOI : 10.1016/S0190-9622(99)70491-3

M. H. Schmid, Tumor Burden Index as a Prognostic Tool for Cutaneous T-Cell Lymphoma, Archives of Dermatology, vol.135, issue.10, pp.135-1204, 1999.
DOI : 10.1001/archderm.135.10.1204

J. R. Toro, Prognostic factors and evaluation of mycosis fungoides and S??zary syndrome, Journal of the American Academy of Dermatology, vol.37, issue.1, pp.58-67, 1997.
DOI : 10.1016/S0190-9622(97)70212-3

F. Vega, Clonal heterogeneity in mycosis fungoides and its relationship to clinical course, Blood, vol.100, issue.9, pp.3369-73, 2002.
DOI : 10.1182/blood.V100.9.3369

R. Willemze and R. C. Beljaards, Spectrum of primary cutaneous CD30 (Ki-1)- positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment, J Am Acad Dermatol, issue.6, pp.28-973, 1993.

F. Grange, Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome. The French Study Group on Cutaneous Lymphomas, Blood, issue.11, pp.93-3637, 1999.

P. L. Zinzani, Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas, Journal of Clinical Oncology, vol.24, issue.9, pp.1376-82, 2006.
DOI : 10.1200/JCO.2005.03.6285

B. Dreno, Standard and new treatments in cutaneous B-cell lymphomas, Journal of Cutaneous Pathology, vol.146, issue.S1, pp.47-51, 2006.
DOI : 10.1089/cbr.2005.20.185

F. Grange, Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas, Blood, vol.103, issue.10, pp.3662-3670, 2004.
DOI : 10.1182/blood-2003-08-2726

S. J. Whittaker, Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas, Therapy algorithm for cutaneous, pp.1095-1107, 2003.
DOI : 10.1046/j.1365-2133.2003.05241.x

M. Duvic and J. C. Cather, EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA, Dermatologic Clinics, vol.18, issue.1, pp.5-23, 1998.
DOI : 10.1016/S0733-8635(05)70155-8

E. C. Vonderheid, Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma, Journal of the American Academy of Dermatology, vol.20, issue.3, pp.416-444, 1989.
DOI : 10.1016/S0190-9622(89)70051-7

J. Carter and K. A. Zug, Phototherapy for cutaneous T-cell lymphoma: Online survey and literature review, Journal of the American Academy of Dermatology, vol.60, issue.1, pp.39-50, 2009.
DOI : 10.1016/j.jaad.2008.08.043

J. J. Herrmann, Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up, Journal of the American Academy of Dermatology, vol.33, issue.2, pp.234-276, 1995.
DOI : 10.1016/0190-9622(95)90241-4

O. Dereure, Treatment of Early Stages of Mycosis Fungoides with Narrowband Ultraviolet B, Dermatology, vol.218, issue.1, pp.1-6, 2009.
DOI : 10.1159/000161114

C. Querfeld, Long-term Follow-up of Patients With Early-Stage Cutaneous T-Cell Lymphoma Who Achieved Complete Remission With Psoralen Plus UV-A Monotherapy, Archives of Dermatology, vol.141, issue.3, pp.141-305, 2005.
DOI : 10.1001/archderm.141.3.305

F. Trautinger, EORTC consensus recommendations for the treatment of mycosis fungoides/S??zary syndrome, European Journal of Cancer, vol.42, issue.8, pp.42-1014, 2006.
DOI : 10.1016/j.ejca.2006.01.025

F. Pavlotsky, UVB in the management of early stage mycosis fungoides, Journal of the European Academy of Dermatology and Venereology, vol.73, issue.5, pp.565-72, 2006.
DOI : 10.1056/NEJM199704103361501

G. Boztepe, Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides, Journal of the American Academy of Dermatology, vol.53, issue.2, pp.242-248, 2005.
DOI : 10.1016/j.jaad.2005.03.012

G. W. Jones, Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group, Journal of the American Academy of Dermatology, vol.47, issue.3, pp.47-364, 2002.
DOI : 10.1067/mjd.2002.123482

B. Dreno, [Interferon alpha in the treatment of cutaneous T-cell lymphoma], Ann Dermatol Venereol, vol.132, issue.2, pp.5-27, 2005.

M. Duvic, Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma, Arch Dermatol, vol.137, issue.5, pp.581-93, 2001.

O. Dereure, [Systemic treatments of cutaneous T-cell lymphomas (except interferon and photopheresis)], Ann Dermatol Venereol, vol.132, issue.2, pp.5-31, 2005.

B. S. Mann, FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma, The Oncologist, vol.12, issue.10, pp.12-1247, 2007.
DOI : 10.1634/theoncologist.12-10-1247

M. Duvic, Phase II Evaluation of Gemcitabine Monotherapy for Cutaneous T-Cell Lymphoma, Clinical Lymphoma and Myeloma, vol.7, issue.1, pp.51-59, 2006.
DOI : 10.3816/CLM.2006.n.039

M. T. Fierro, Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP, Leuk Lymphoma, pp.31-36, 1998.

L. Laroche, [Photopheresis for cutaneous T-cell lymphomas], Ann Dermatol Venereol, vol.132, issue.2, pp.5-37, 2005.

J. Guitart, Long-term Remission After Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T-Cell Lymphoma, Archives of Dermatology, vol.138, issue.10, pp.138-1359, 2002.
DOI : 10.1001/archderm.138.10.1359

T. Abou-samra, R. Viraben, and M. D. Incan, New immunomodulating treatments in evaluation for cutaneous T-cell lymphomas], Ann Dermatol Venereol, vol.132, issue.2, pp.5-39, 2005.

J. Lundin, Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome, Blood, vol.101, issue.11, pp.4267-72, 2003.
DOI : 10.1182/blood-2002-09-2802

E. C. Vonderheid, A. Sajjadian, and M. E. Kadin, Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders, Journal of the American Academy of Dermatology, vol.34, issue.3, pp.470-81, 1996.
DOI : 10.1016/S0190-9622(96)90442-9

B. D. Smith, Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems, Journal of Clinical Oncology, vol.22, issue.4, pp.634-643, 2004.
DOI : 10.1200/JCO.2004.08.044

N. J. Senff, Results of Radiotherapy in 153 Primary Cutaneous B-Cell Lymphomas Classified According to the WHO-EORTC Classification, Archives of Dermatology, vol.143, issue.12, pp.143-1520, 2007.
DOI : 10.1001/archderm.143.12.1520

U. Wollina, S. Hahnfeld, and H. Kosmehl, Primary cutaneous marginal center lymphoma - complete remission induced by interferon ??2a, Journal of Cancer Research and Clinical Oncology, vol.125, issue.5, pp.305-313, 1999.
DOI : 10.1007/s004320050278

A. Cozzio, Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma, Leuk Lymphoma, issue.5, pp.47-865, 2006.

K. Kerl, Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases, British Journal of Dermatology, vol.15, issue.6, pp.155-1197, 2006.
DOI : 10.1111/j.1365-2133.2005.06433.x

M. W. Bekkenk, Treatment of Multifocal Primary Cutaneous B-Cell Lymphoma: A Clinical Follow-Up Study of 29 Patients, Journal of Clinical Oncology, vol.17, issue.8, pp.17-2471, 1999.
DOI : 10.1200/JCO.1999.17.8.2471

C. Bachmeyer, V. Orlandini, and S. Aractingi, Topical mechlorethamine and clobetasol in multifocal primary cutaneous marginal zone-B cell lymphoma, Br J Dermatol, vol.154, issue.6, pp.1207-1216, 2006.

L. M. Heinzerling, Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma, Cancer, issue.8, pp.89-1835, 2000.

J. U. Rijlaarsdam, Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy., Journal of Clinical Oncology, vol.14, issue.2, pp.549-55, 1996.
DOI : 10.1200/JCO.1996.14.2.549

C. Assaf, Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG), JDDG, vol.97, issue.12, pp.662-670, 2007.
DOI : 10.1034/j.1600-0560.2001.281002.x

M. A. Bogle, Primary cutaneous B-cell lymphoma, Journal of the American Academy of Dermatology, vol.53, issue.3, pp.479-84, 2005.
DOI : 10.1016/j.jaad.2005.04.043

F. Gallardo, Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma, Human Pathology, vol.37, issue.7, pp.37-867, 2006.
DOI : 10.1016/j.humpath.2006.02.012

G. Palmedo, Primary Cutaneous Marginal Zone B-cell Lymphoma May Exhibit Both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 Translocation: An Indicator for Clonal Transformation Towards Higher-Grade B-cell Lymphoma?, The American Journal of Dermatopathology, vol.29, issue.3, pp.29-231, 2007.
DOI : 10.1097/DAD.0b013e31804795a6

B. Streubel, T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma, Blood, vol.101, issue.6, pp.2335-2344, 2003.
DOI : 10.1182/blood-2002-09-2963

B. Streubel, T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma, Leukemia, vol.14, issue.4, pp.652-660, 2005.
DOI : 10.1073/PNAS.050007597